The use of coronary sinus reducer for refractory angina in the U.S.: A case series

Authors

Ryan Gindi, Henry Ford HealthFollow
Sarah Gorgis, Henry Ford HealthFollow
Mohamed Raad, Henry Ford HealthFollow
William O'Neill, Henry Ford HealthFollow
Gerald C. Koenig, Henry Ford HealthFollow

Recommended Citation

Gindi R, Gorgis S, Raad M, O'Neill W, and Koenig G. The use of coronary sinus reducer for refractory angina in the U.S.: A case series. Cardiovasc Revasc Med 2022.

Document Type

Article

Publication Date

1-11-2022

Publication Title

Cardiovasc Revasc Med

Abstract

Chronic refractory angina remains a common and debilitating condition for millions of people, with up to 30% of patients experiencing persistent angina despite successful revascularization. We share our experience with the implantation of a coronary sinus reducer in two complex CAD patients with refractory angina despite multiple revascularization strategies and maximally tolerated medical therapy.

PubMed ID

35042667

ePublication

ePub ahead of print